2018 update of the EULAR recommendations for the management of Behçet's syndromeGülen Hatemi, Hasan Yazıcı, David Saadoun et al.|Annals of the Rheumatic Diseases|2018Cited by 771
EULAR recommendations for the management of Behçet diseaseGülen Hatemi, Hasan Yazıcı, Alan J. Silman et al.|Annals of the Rheumatic Diseases|2008Cited by 721
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Antonella Insalaco et al.|Frontiers in Pharmacology|2019Cited by 616
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet diseaseGülen Hatemi, Hasan Yazıcı, A J Silman et al.|Annals of the Rheumatic Diseases|2008Cited by 201
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life SettingMariele Gatto, Roberto Gerli, Francesca Saccon et al.|Arthritis & Rheumatology|2020Cited by 113